)
Edge
Extra Everything: The Story of Chipotle
Chipotle's story from a single restaurant to a nationwide chain, through crisis and turnaround, built on one of the strongest models in the industry.
Shukra Pharmaceuticals
Shukra Pharmaceuticals (524632) investor relations material
Shukra Pharmaceuticals Q4 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 25/26 earnings summary7 May, 2026
Executive summary
Audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, were approved, with an unmodified audit opinion from statutory auditors.
A final dividend of ₹0.01 per equity share was recommended for FY 2025-26, subject to shareholder approval.
1,735,000 equity shares were allotted to promoters upon conversion of warrants, increasing paid-up capital.
Financial highlights
Consolidated revenue from operations for FY 2025-26 was ₹5,672.74 lakhs, up from ₹3,258.73 lakhs year-over-year.
Consolidated net profit for FY 2025-26 was ₹2,205.84 lakhs, compared to ₹957.51 lakhs in the previous year.
Standalone revenue for FY 2025-26 was ₹5,670.61 lakhs, with net profit at ₹2,204.79 lakhs, both showing significant year-over-year growth.
Earnings per share (EPS) for FY 2025-26 stood at ₹0.50 (basic and diluted) on both standalone and consolidated basis.
Total assets as of March 31, 2026, were ₹11,744.00 lakhs (consolidated), up from ₹8,677.32 lakhs year-over-year.
Outlook and guidance
No deviation or variation in the utilization of proceeds from preferential issue; funds used as planned for working capital, debt repayment, and capital expenditure.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Shukra Pharmaceuticals
- Q3 FY26 revenue and profit surged, with strong audit review and MD re-appointment.524632
Q3 25/264 Feb 2026 - Q2 FY26 saw higher revenue, profit, and cash, with clean auditor review and no complaints.524632Q2 25/2613 Nov 2025
- Q1 FY26 saw strong revenue and profit growth with clean auditor review.524632Q1 25/2613 Aug 2025
- Q2 FY2024-25 revenue grew, but net profit and EPS fell; cash reserves increased.524632Q2 24/2513 Jun 2025
- Q1 FY25 saw a significant drop in revenue and profit, but auditors raised no concerns.524632Q1 24/2513 Jun 2025
- FY25 revenue and profit declined sharply, but financial position and compliance remain strong.524632Q4 24/256 Jun 2025
- Quarterly profit and revenue surged, with strengthened audit oversight.524632Q3 24/256 Jun 2025
Next Shukra Pharmaceuticals earnings date
Q1 26/2712 Aug, 2026
Shukra Pharmaceuticals
Next Shukra Pharmaceuticals earnings date
Q1 26/2712 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
Explore our global coverage